Literature DB >> 26085990

Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism.

Wei-Wei Zhang1, Xin Wang2, Ping Xie1, Song-Tao Yuan1, Qing-Huai Liu1.   

Abstract

AIM: To prove anthrax lethal toxin (LeTx) blocks the mitogen activated protein kinases (MAPKs) activation by degrading the MAPK/ERK kinases (MEKs) to suppress vascular endothelial growth factor (VEGF) secretion.
METHODS: Human adult retinal pigmented epithelium (ARPE) cells were cultured and treated with normal glucose, high glucose or high glucose with LeTx for additional 24, 48 or 72h for viable cell count. Total RNA from the ARPE was isolated for reverse transcription polymerase chain reaction (RT-PCR). The conditioned medium of ARPE cells treated in different group for 48h was filtered and diluted to detect the concentration of VEGF by enzyme-linked immunosorbant assays. Evaluate the role of MEK/MAPK pathway in the secretion of VEGF by immunoblotting.
RESULTS: In this study, we proved high glucose induced activation of the MAPK extracellular signal-regulated kinase (ERK1/2) and p38 in the ARPE cell line was blocked by anthrax LeTx. LeTx also inhibited high glucose induced ARPE cell over proliferation.
CONCLUSION: LeTx suppressed high glucose induced VEGF over secretion in the ARPE cells, mainly through a post-translational mechanism.

Entities:  

Keywords:  angiogenesis; anthrax lethal toxin; diabetic retinopathy; retinal pigmented epithelium; vascular endothelial growth factor

Year:  2015        PMID: 26085990      PMCID: PMC4458645          DOI: 10.3980/j.issn.2222-3959.2015.03.04

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  36 in total

1.  Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats.

Authors:  Qing-you Meng; Xiao-qiang Li; Xiao-bin Yu; Feng-rui Lei; Kun Jiang; Chuan-yong Li
Journal:  Chin Med J (Engl)       Date:  2010-02-20       Impact factor: 2.628

Review 2.  MKK signaling and vascularization.

Authors:  P E Depeille; Y Ding; J L Bromberg-White; N S Duesbery
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

3.  Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.

Authors:  Zongzhong Tong; Zhenglin Yang; Shrena Patel; Haoyu Chen; Daniel Gibbs; Xian Yang; Vincent S Hau; Yuuki Kaminoh; Jennifer Harmon; Erik Pearson; Jeanette Buehler; Yuhong Chen; Baifeng Yu; Nicholas H Tinkham; Norman A Zabriskie; Jiexi Zeng; Ling Luo; Jennifer K Sun; Manvi Prakash; Rola N Hamam; Stephen Tonna; Ryan Constantine; Cecinio C Ronquillo; SriniVas Sadda; Robert L Avery; John M Brand; Nyall London; Alfred L Anduze; George L King; Paul S Bernstein; Scott Watkins; Lynn B Jorde; Dean Y Li; Lloyd Paul Aiello; Martin R Pollak; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

4.  Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.

Authors:  Xiaoqin Wang; Guibo Wang; Yi Wang
Journal:  Am J Ophthalmol       Date:  2009-10-17       Impact factor: 5.258

5.  Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.

Authors:  Yunpeng Du; Jie Tang; Guangyuan Li; Guanyuan Li; Liliana Berti-Mattera; Chieh Allen Lee; Darian Bartkowski; David Gale; Joe Monahan; Michael R Niesman; Gordon Alton; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

Review 6.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

Review 7.  Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.

Authors:  Mariacristina Parravano; Francesca Menchini; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.

Authors:  Yan Ding; Elissa A Boguslawski; Bree D Berghuis; John J Young; Zhongfa Zhang; Kim Hardy; Kyle Furge; Eric Kort; Arthur E Frankel; Rick V Hay; James H Resau; Nicholas S Duesbery
Journal:  Mol Cancer Ther       Date:  2008-03-04       Impact factor: 6.261

9.  Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.

Authors:  Young Won Yoon; Tae Soo Kang; Byoung Kwon Lee; Woochul Chang; Ki-Chul Hwang; Ji-Hyuck Rhee; Pil-Ki Min; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

10.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.